Acquired platelet dysfunction in 109 patients from a tertiary care referral hospital

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 1, 2011, Pages 88-93

  Sharma, Prashant ^a   Kar, Rakhee ^a   Bhargava, Rahul ^a   Ranjan, Ravi ^a   Pravas Chandra Mishra, ^a   Saxena, Renu ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

acquired platelet dysfunction; bleeding; drug induced disorder; light transmission platelet aggregometry; myeloproliferative neoplasm; plasma cell dyscrasia; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CHLORPROMAZINE; CLOPIDOGREL; HALOTHANE; LOSARTAN; PENICILLIN G; PROPRANOLOL; THROMBOCYTE FACTOR 3; TICLOPIDINE; VALPROIC ACID;

ACQUIRED PLATELET FUNCTION DEFECT; ARTICLE; BLEEDING; BLEEDING TIME; CHRONIC LIVER DISEASE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CARCINOMA; DISSEMINATED INTRAVASCULAR CLOTTING; FALLOT TETRALOGY; GAUCHER DISEASE; HUMAN; HYPOTHYROIDISM; IDIOPATHIC DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MYELOID METAPLASIA; MYELOMA; PARTIAL THROMBOPLASTIN TIME; PERITONEUM PSEUDOMYXOMA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SIDEROBLASTIC ANEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; THALASSEMIA MAJOR; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; UREMIA; WALDENSTROEM MACROGLOBULINEMIA;

BLOOD PLATELET DISORDERS; FEMALE; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROTHROMBIN TIME; REFERRAL AND CONSULTATION; THROMBIN TIME;

EID: 78651406676     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029610379397     Document Type: Article

References (20)

1. Asthana B., Sharma P., Ranjan R., et al. Patterns of acquired bleeding disorders in a tertiary care hospital. Clin Appl Thromb Hemost. 2009 ; 15 (4). 448-453.
2. Shen YP, Frenkel EP Acquired platelet dysfunction. Hematol Oncol Clin N Am. 2007 ; 21 (4). 647-661.
3. Miller AB, Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 ; 47 (1). 207-214.
4. Gupta PK, Ahmed R., Kannan M., Chatterjee T., Choudhry VP, Saxena R. Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease. Ann Hematol. 2004 ; 83 (7). 489-490.
5. Saxena R., Pati HP, Kannan M., Ahmad F. Investigation of bleeding disorders. In: Saxena R, Pati HP, eds. Laboratory Techniques in Hematology. New Delhi: Jaypee Brothers Medical Publishers; 2008: 135-196.
6. Hassan AA, Kroll MH Acquired disorders of platelet function. Hematology Am Soc Hematol Educ Program. 2005: 403-8.
7. Kroll MH, Hassan AA Acquired disorders of platelet function. In: Gresele P, Fuster V, López JA, Page CP, Vermylen J, eds. Platelets in Hematologic and Cardiovascular Disorders: A Clinical Handbook. Cambridge: Cambridge University Press; 2008: 225-241.
8. Bennett JS Acquired platelet function defects. In: Gresele P, Page CP, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics. Cambridge: Cambridge University Press; 2002: 689-706.
9. Dacie JV, Lewis SM Practical Haematology. 9 th ed. Edinburgh, Scotland: Churchill Livingstone ; 2001.
10. Girolami A., Luzzatto G., Varvarikis C., Pellati D., Sartori R., Girolami B. Main clinical manifestations of a bleeding diathesis: an often disregarded aspect of medical and surgical history taking. Haemophilia. 2005 ; 11 (3). 193-202.
11. Peterson P., Hayes TE, Arkin CF, et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg. 1998 ; 133 (2). 134-139.
12. Gewirtz AS, Miller ML, Keys TF The clinical usefulness of the preoperative bleeding time. Arch Pathol Lab Med. 1996 ; 120 (4). 353-356.
13. Ahmad F., Kannan M., Ranjan R., Bajaj J., Choudhary VP, Saxena R. Inherited platelet function disorders versus other inherited bleeding disorders: an Indian overview. Thromb Res. 2008 ; 121 (6). 835-841.
14. Gupta PK, Charan VD, Saxena R. Spectrum of Von Willebrand disease and inherited platelet function disorders amongst Indian bleeders. Ann Hematol. 2007 ; 86 (6). 403-407.
15. Huebsch LB, Harker LA Disorders of platelet function: mechanisms, diagnosis and management. West J Med. 1981 ; 134 (2). 109-127.
16. Bhattacharyya M., Kannan M., Chaudhry VP, Mahapatra M., Pati H., Saxena R. Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost. 2007 ; 13 (4). 422-427.
17. Hussain MA, Hutton RA, Pavlidou O., Hoffbrand AV Platelet function in beta-thalassaemia major. J Clin Pathol. 1979 ; 32 (5). 429-433.
18. Witters P., Freson K., Verslype C., et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008 ; 27 (11). 1017-1029.
19. Escolar G., Díaz-Ricart M., Cases A. Uremic platelet dysfunction: past and present. Curr Hematol Rep. 2005 ; 4 (5). 359-367.
20. Bray PF Platelet hyperreactivity: predictive and intrinsic properties. Hematol Oncol Clin North Am. 2007 ; 21 (4). 633-645 ; v - vi.